Latest Clinical research Stories
CHAPEL HILL, N.C., May 22, 2015 /PRNewswire/ -- Research and Benchmarking firm, Best Practices, LLC will be hosting its sixth
ROCKVILLE, Md., May 22, 2015 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage drug development company focused on tissue protection, repair and regeneration,
NEW YORK, May 22, 2015 /PRNewswire/ -- The U.S.
Statistically Significant Findings Identify Key Efficacy Targets for Phase IIb/III Clinical Trial with RGN-259 ROCKVILLE, Md., May 22, 2015 /PRNewswire/ -- RegeneRx Biopharmaceuticals,
DUBLIN, May 22, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/3rthk2/latest)
- Unanimous Recommendation to Grant European Marketing Authorization for Omidria Based on Benefit/Risk Profile - SEATTLE, May 22, 2015 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER),
REDWOOD CITY, Calif., May 22, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
PhUSE, the voice of clinical data scientists towards standard organizations and regulatory agencies, published a set of data de-identification rules as an outcome from a working group with representatives
SHANGHAI, May 21, 2015 /PRNewswire/ -- A consortium ("the Consortium") consisting of entities affiliated with Shanghai Fosun Pharmaceutical Group, HOPU Investments, China Everbright
- A handkerchief.
- Specifically— The legendary sweat-cloth; the handkerchief of St. Veronica, according to tradition miraculously impressed with the mask of Christ; also, the napkin about Christ's head (Johu xx. 7).
- In general, any miraculous portrait of Christ.